• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种显性负性Flk-1突变体在体内抑制胶质母细胞瘤生长。

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.

作者信息

Millauer B, Shawver L K, Plate K H, Risau W, Ullrich A

机构信息

Department of Molecular Biology, Max-Planck-Institut für Biochemie, Martinsried, Germany.

出版信息

Nature. 1994 Feb 10;367(6463):576-9. doi: 10.1038/367576a0.

DOI:10.1038/367576a0
PMID:8107827
Abstract

Angiogenesis, the sprouting of capillaries from pre-existing blood vessels, is a fundamental process in the formation of the vascular system during embryonic development. In adulthood, angiogenesis takes place during corpus luteum formation and in pathological conditions such as wound healing, diabetic retinopathy, and tumor-igenesis. Vascularization is essential for solid tumour growth and is thought to be regulated by tumour cell-produced factors, which have a chemotactic and mitogenic effect on endothelial cells. Vascular endothelial growth factor (VEGF), a homodimeric glycoprotein of relative molecular mass 45,000, is the only mitogen, however, that specifically acts on endothelial cells, and it may be a major regulator of tumour angiogenesis in vivo. Its expression has been shown to be upregulated by hypoxia, and its cell-surface receptor, Flk-1, is exclusively expressed in endothelial cells. Here we investigate the biological relevance of the VEGF/Flk-1 receptor/ligand system for angiogenesis using a retrovirus encoding a dominant-negative mutant of the Flk-1/VEGF receptor to infect endothelial target cells in vivo, and find that tumour growth is prevented in nude mice. Our results emphasize the central role of the Flk-1/VEGF system in angiogenesis in general and in the development of solid tumours in particular.

摘要

血管生成,即从已有的血管中生出毛细血管,是胚胎发育过程中血管系统形成的一个基本过程。在成年期,血管生成发生在黄体形成过程中以及诸如伤口愈合、糖尿病视网膜病变和肿瘤发生等病理状况下。血管形成对于实体肿瘤的生长至关重要,并且被认为受肿瘤细胞产生的因子调控,这些因子对内皮细胞具有趋化作用和促有丝分裂作用。血管内皮生长因子(VEGF)是一种相对分子质量为45,000的同二聚体糖蛋白,然而它是唯一特异性作用于内皮细胞的促有丝分裂原,并且它可能是体内肿瘤血管生成的主要调节因子。其表达已被证明受缺氧上调,并且其细胞表面受体Flk-1仅在内皮细胞中表达。在这里,我们使用编码Flk-1/VEGF受体显性负性突变体的逆转录病毒在体内感染内皮靶细胞,研究VEGF/Flk-1受体/配体系统对血管生成的生物学相关性,并发现裸鼠的肿瘤生长受到抑制。我们的结果强调了Flk-1/VEGF系统在一般血管生成中,特别是在实体肿瘤发展中的核心作用。

相似文献

1
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.一种显性负性Flk-1突变体在体内抑制胶质母细胞瘤生长。
Nature. 1994 Feb 10;367(6463):576-9. doi: 10.1038/367576a0.
2
KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.KDR/Flk-1是血管内皮生长因子诱导的小鼠肝癌细胞肿瘤发展和血管生成的主要调节因子。
Hepatology. 1999 Nov;30(5):1179-86. doi: 10.1002/hep.510300509.
3
Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo.血管内皮生长因子(VEGF)和血管内皮生长因子受体2(flk-1)在鹌鹑胚胎血管发生和血管分化过程中表达。
Dev Biol. 1995 Jun;169(2):699-712. doi: 10.1006/dbio.1995.1180.
4
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.Flk-1的显性负性抑制在体内可抑制多种肿瘤类型的生长。
Cancer Res. 1996 Apr 1;56(7):1615-20.
5
Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.血管内皮生长因子受体-1(flt-1)及其配体的协同表达提示了对小鼠血管发育的旁分泌调节。
Dev Dyn. 1995 Nov;204(3):228-39. doi: 10.1002/aja.1002040303.
6
Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation.禽类胚胎中血管内皮生长因子的过表达会诱导血管过度生成并增加血管通透性,而不会改变胚胎模式形成。
Dev Biol. 1995 Oct;171(2):399-414. doi: 10.1006/dbio.1995.1291.
7
Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development.小鼠胚胎的血管形成:发育过程中flk-1、tek、tie及血管内皮生长因子表达的研究
Dev Dyn. 1995 May;203(1):80-92. doi: 10.1002/aja.1002030109.
8
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.由orf病毒编码的一种新型血管内皮生长因子VEGF-E,通过VEGFR-2(KDR)而非VEGFR-1(Flt-1)受体酪氨酸激酶发出的信号介导血管生成。
EMBO J. 1999 Jan 15;18(2):363-74. doi: 10.1093/emboj/18.2.363.
9
Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system.在脑片培养系统中,其配体对flk-1/血管内皮生长因子受体2的上调作用。
Cancer Res. 1997 Sep 1;57(17):3852-9.
10
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.VEGF基因靶向失活诱导的杂合子胚胎致死性
Nature. 1996 Apr 4;380(6573):439-42. doi: 10.1038/380439a0.

引用本文的文献

1
Progressive Deactivation of Hydroxylases Controls Hypoxia-Inducible Factor-1α-Coordinated Cellular Adaptation to Graded Hypoxia.羟化酶的渐进性失活控制缺氧诱导因子-1α协调的细胞对分级缺氧的适应性。
Research (Wash D C). 2025 Apr 1;8:0651. doi: 10.34133/research.0651. eCollection 2025.
2
A Systematic Review of Tear Vascular Endothelial Growth Factor and External Eye Diseases.泪液血管内皮生长因子与眼表疾病的系统评价
Int J Mol Sci. 2024 Jan 23;25(3):1369. doi: 10.3390/ijms25031369.
3
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.
NRG/RTOG 0837:新诊断胶质母细胞瘤同步放化疗联合或不联合西地尼布的随机、II期、双盲、安慰剂对照试验
Neurooncol Adv. 2023 Oct 11;5(1):vdad116. doi: 10.1093/noajnl/vdad116. eCollection 2023 Jan-Dec.
4
Cytotoxic Potential of Novel Quinoline Derivative: 11-(1,4-Bisaminopropylpiperazinyl)5-methyl-5H-indolo[2,3-b]quinoline against Different Cancer Cell Lines via Activation and Deactivation of the Expression of Some Proteins.新型喹啉衍生物:11-(1,4-双氨丙基哌嗪基)-5-甲基-5H-吲哚并[2,3-b]喹啉通过激活和失活某些蛋白质表达对不同癌细胞系的细胞毒性潜力
Int J Mol Sci. 2023 Sep 20;24(18):14336. doi: 10.3390/ijms241814336.
5
Design and cytotoxic evaluation via apoptotic and antiproliferative activity for novel 11(4-aminophenylamino)neocryptolepine on hepatocellular and colorectal cancer cells.新型 11(4-氨基苯氨基)新隐卡品对肝癌和结直肠癌细胞的设计及细胞毒性评价:凋亡和抗增殖活性。
Apoptosis. 2023 Apr;28(3-4):653-668. doi: 10.1007/s10495-023-01810-y. Epub 2023 Jan 31.
6
Regression of Human Breast Carcinoma in Nude Mice after Ad Gene Therapy Is Mediated by Tumor Vascular Endothelial Cell Apoptosis.腺病毒基因治疗后裸鼠人乳腺癌的消退由肿瘤血管内皮细胞凋亡介导。
Cancers (Basel). 2022 Dec 14;14(24):6175. doi: 10.3390/cancers14246175.
7
Mutual regulation between phosphofructokinase 1 platelet isoform and VEGF promotes glioblastoma tumor growth.磷酸果糖激酶 1 血小板同工酶与 VEGF 之间的相互调节促进胶质母细胞瘤肿瘤生长。
Cell Death Dis. 2022 Nov 26;13(11):1002. doi: 10.1038/s41419-022-05449-6.
8
Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges.利用抗血管生成药物提高抗肿瘤免疫:机制见解、当前进展和临床挑战。
Cancer Commun (Lond). 2021 Sep;41(9):830-850. doi: 10.1002/cac2.12183. Epub 2021 Jun 17.
9
VEGFC/FLT4-induced cell-cycle arrest mediates sprouting and differentiation of venous and lymphatic endothelial cells.VEGFC/FLT4 诱导的细胞周期停滞介导静脉和淋巴管内皮细胞的出芽和分化。
Cell Rep. 2021 Jun 15;35(11):109255. doi: 10.1016/j.celrep.2021.109255.
10
Therapeutic and nutraceutical potentials of a brown seaweed .一种褐藻的治疗和营养保健潜力
Food Sci Nutr. 2020 Aug 20;8(10):5195-5205. doi: 10.1002/fsn3.1835. eCollection 2020 Oct.